Plus Therapeutics (PSTV) Preferred Dividend Payments (2014 - 2019)

Plus Therapeutics (PSTV) has 5 years of Preferred Dividend Payments data on file, last reported at $554000.0 in Q3 2019.

• Preferred Dividend Payments for Q3 2019 came in at $554000.0, down 77.72% year-over-year; the trailing twelve-month figure through Dec 2019 was $3.0 million (down 52.95% YoY), and the FY2019 annual result was $554000.0, down 77.72% from the prior year.
• Preferred Dividend Payments fell to $554000.0 in Q3 2019 per PSTV's latest filing, from $2.5 million in the prior quarter.
• Over five years, Preferred Dividend Payments peaked at $4.0 million in Q4 2017 and troughed at $554000.0 in Q3 2019.
• A 4-year average of $1.9 million and a median of $1.6 million in 2015 frame the typical range for Preferred Dividend Payments.
• On a YoY basis, Preferred Dividend Payments climbed as much as 77.72% in 2019 and fell as far as 77.72% in 2019.
• A 4-year view of Preferred Dividend Payments shows it stood at $661000.0 in 2015, then jumped by 501.66% to $4.0 million in 2017, then plunged by 37.47% to $2.5 million in 2018, then slumped by 77.72% to $554000.0 in 2019.
• Business Quant data shows PSTV's Preferred Dividend Payments at $554000.0 in Q3 2019, $2.5 million in Q3 2018, and $4.0 million in Q4 2017.